407 related articles for article (PubMed ID: 20466069)
1. State-of-the-art genomics approaches in toxicology.
Van Hummelen P; Sasaki J
Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
[TBL] [Abstract][Full Text] [Related]
2. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.
Waters MD; Jackson M; Lea I
Mutat Res; 2010 Dec; 705(3):184-200. PubMed ID: 20399889
[TBL] [Abstract][Full Text] [Related]
3. The state-of-the-art in predictive toxicogenomics.
Fielden MR; Kolaja KL
Curr Opin Drug Discov Devel; 2006 Jan; 9(1):84-91. PubMed ID: 16445120
[TBL] [Abstract][Full Text] [Related]
4. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
[TBL] [Abstract][Full Text] [Related]
5. Toxicogenomics in predictive toxicology in drug development.
Suter L; Babiss LE; Wheeldon EB
Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
[TBL] [Abstract][Full Text] [Related]
6. The promise of toxicogenomics.
Waring JF; Halbert DN
Curr Opin Mol Ther; 2002 Jun; 4(3):229-35. PubMed ID: 12139308
[TBL] [Abstract][Full Text] [Related]
7. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
Lühe A; Suter L; Ruepp S; Singer T; Weiser T; Albertini S
Mutat Res; 2005 Aug; 575(1-2):102-15. PubMed ID: 15924886
[TBL] [Abstract][Full Text] [Related]
8. Strategic applications of toxicogenomics in early drug discovery.
Ryan TP; Stevens JL; Thomas CE
Curr Opin Pharmacol; 2008 Oct; 8(5):654-60. PubMed ID: 18760379
[TBL] [Abstract][Full Text] [Related]
9. Toxicogenomics in drug discovery: from preclinical studies to clinical trials.
Yang Y; Blomme EA; Waring JF
Chem Biol Interact; 2004 Nov; 150(1):71-85. PubMed ID: 15522262
[TBL] [Abstract][Full Text] [Related]
10. Toxicogenomics in biomarker discovery.
Decristofaro MF; Daniels KK
Methods Mol Biol; 2008; 460():185-94. PubMed ID: 18449488
[TBL] [Abstract][Full Text] [Related]
11. Predictive toxicogenomics in preclinical discovery.
Barros SA; Martin RB
Methods Mol Biol; 2008; 460():89-112. PubMed ID: 18449484
[TBL] [Abstract][Full Text] [Related]
12. The importance of applying toxicogenomics to increase the efficiency of drug discovery.
Barros SA
Pharmacogenomics; 2005 Sep; 6(6):547-50. PubMed ID: 16142994
[No Abstract] [Full Text] [Related]
13. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
14. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
Stierum R; Heijne W; Kienhuis A; van Ommen B; Groten J
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):179-88. PubMed ID: 16139318
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomics in predictive toxicology.
Storck T; von Brevern MC; Behrens CK; Scheel J; Bach A
Curr Opin Drug Discov Devel; 2002 Jan; 5(1):90-7. PubMed ID: 11865677
[TBL] [Abstract][Full Text] [Related]
16. Application of genomics in preclinical drug safety evaluation.
Lord PG; Nie A; McMillian M
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):537-46. PubMed ID: 16700814
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates.
Kramer JA; Sagartz JE; Morris DL
Nat Rev Drug Discov; 2007 Aug; 6(8):636-49. PubMed ID: 17643090
[TBL] [Abstract][Full Text] [Related]
19. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
Youns M; Hoheisel JD; Efferth T
Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
[TBL] [Abstract][Full Text] [Related]
20. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
